Darrell Nix

Author PubWeight™ 8.47^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer.	J Clin Oncol	2004	3.02
2	Bortezomib in recurrent and/or refractory multiple myeloma. Initial clinical experience in patients with impared renal function.	Cancer	2005	1.50
3	A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.	Arthritis Rheum	2009	1.38
4	Human metabolism of the proteasome inhibitor bortezomib: identification of circulating metabolites.	Drug Metab Dispos	2005	1.34
5	Investigation of drug-drug interaction potential of bortezomib in vivo in female Sprague-Dawley rats and in vitro in human liver microsomes.	Drug Metab Dispos	2006	0.86
6	Effect of a Novel, Orally Active Matrix Metalloproteinase-2 and -9 Inhibitor in Spinal and Trigeminal Rat Models of Neuropathic Pain.	J Oral Facial Pain Headache	2015	0.78